Prediction Scores Identifying Patients at High Risk of Endocarditis in Enterococcal Bacteremia
Both adapted NOVA and DENOVi scores reliably ruled out IE, but DENOVi provided the most balanced approach between diagnostic safety and resource utilization. DENOVi therefore represents a pragmatic and objective tool for IE risk stratification in enterococcal bacteremia. Prospective validation is warranted.
Authors
- Laurence Senn (ORCID: https://orcid.org/0000-0001-7198-1625)
- Jana Epprecht (ORCID: https://orcid.org/0000-0003-3277-7044)
- Benoît Guéry (ORCID: https://orcid.org/0000-0002-6526-0714)
- Mathias Van Hemelrijck (ORCID: https://orcid.org/0000-0002-0191-757X)
- Barbara Hasse (ORCID: https://orcid.org/0000-0001-7196-3734)
- G. Tzimas (ORCID: https://orcid.org/0000-0002-2593-5166)
- Pierre Monney (ORCID: https://orcid.org/0000-0002-3083-7333)
- Nicoleta Ianculescu
- Nicolas Fourré (ORCID: https://orcid.org/0009-0006-1660-9365)
- Lars Niclauss (ORCID: https://orcid.org/0000-0003-4453-5202)
- Virgile Zimmermann (ORCID: https://orcid.org/0009-0005-1812-0216)
- M. Frank
- Matthias Kirsch
- Bruno Ledergerber
- Matthaios Papadimitriou-Olivgeris
- Omer Dzemali
Institutions
- University of Zurich (CH)
- Triemli Hospital (CH)
- University Hospital of Zurich (CH)
- Hôpital du Valais (CH)
- University of Lausanne (CH)
Publication Details
- Journal
- Open Forum Infectious Diseases
- Published
- 2025-12-20
- DOI
- https://doi.org/10.1093/ofid/ofaf796
- Primary Topic
- Infective Endocarditis Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Science Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Schweizerische Herzstiftung